Noben, Lore
Westerhuis, Michelle E. M. H.
van Laar, Judith O. E. H.
Kok, René D.
Oei, S. Guid
Peters, Chris H. L.
Vullings, Rik
Funding for this research was provided by:
Stichting De Weijerhorst
Article History
Received: 8 November 2019
Accepted: 1 April 2020
First Online: 15 April 2020
Ethics approval and consent to participate
: Our research complies with the guidelines for human studies and was conducted in accordance with the World Medical Association Declaration of Helsinki. We received a statement of the Institutional Review Board of the Máxima Medical Centre stating that no ethical approval was required (N18.074).Written informed consent was obtained from participant before inclusion.
: We obtained written consent from the participant described in our manuscript for publication of potentially identifying images and clinical details.
: L Noben: none declared.MEMH Westerhuis: none declared.JOEH van Laar: none declared.RD Kok: R. Kok is vice-president medical affairs at NEMO Healthcare BV.SG Oei: SG Oei initiated the scientific research from which Nemo Healthcare BV has originated. There is no financial relationship between SG Oei and Nemo Healthcare BV.CHL Peters: CHL Peters is shareholder in NEMO Healthcare BV.R Vullings: R Vullings is shareholder in NEMO Healthcare BV.